Assessment of Stimulant Use and Cardiovascular Event Risks Among Older Adults
Authors:
Open Access
- 25 October 2021
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 4 (10) , e2130795
Abstract
Stimulants act on the central nervous system (CNS) to increase alertness, attention, and energy.1,2 Although stimulants are most commonly used among children and youth for the treatment of attention-deficit/hyperactivity disorder (ADHD),3,4 an increase in stimulant use among older adults in recent years has been observed.5 Off-label uses of stimulants among older adults include the treatment of depression, poststroke recovery, motor function, and fatigue.2,6-13 This increase in use has been reported despite concerns regarding cardiovascular (CV) safety.14-19 Because of their effects on monoamine transmission, stimulants increase resting heart rate and systolic blood pressure. A meta-analysis of 10 randomized clinical trials reported that stimulants were associated with an increase in heart rate of 5.7 beats per minute (bpm) and in systolic blood pressure of 2.0 mm Hg.14 Furthermore, the use of methylphenidate was associated with a 4-fold increase in the odds of developing prehypertension among younger adults who were previously normotensive, and use of this stimulant has been associated with increased platelet aggregation.20-22Keywords
This publication has 50 references indexed in Scilit:
- Amphetamines, Atomoxetine and the Risk of Serious Cardiovascular Events in AdultsPLOS ONE, 2013
- Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic reviewBMC Cardiovascular Disorders, 2012
- Stimulants and Cardiovascular Events in Youth With Attention-Deficit/Hyperactivity DisorderJournal of the American Academy of Child & Adolescent Psychiatry, 2012
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged AdultsJAMA, 2011
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational StudiesMultivariate Behavioral Research, 2011
- Covariate Selection in High-Dimensional Propensity Score Analyses of Treatment Effects in Small SamplesAmerican Journal of Epidemiology, 2011
- Optimal caliper widths for propensity‐score matching when estimating differences in means and differences in proportions in observational studiesPharmaceutical Statistics, 2011
- The Burden of Cardiovascular Disease in the Elderly: Morbidity, Mortality, and CostsClinics in Geriatric Medicine, 2009
- High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims DataEpidemiology, 2009
- Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeuticsPharmacoepidemiology and Drug Safety, 2006